REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,699,000 | +30.8% | 516,855 | +2.4% | 0.00% | +100.0% |
| Q3 2016 | $8,178,000 | +16.8% | 504,521 | -2.0% | 0.00% | 0.0% |
| Q2 2016 | $7,003,000 | -18.5% | 514,939 | +4.6% | 0.00% | 0.0% |
| Q1 2016 | $8,597,000 | -42.7% | 492,407 | +12.1% | 0.00% | -50.0% |
| Q4 2015 | $15,010,000 | +72.8% | 439,399 | +50.6% | 0.00% | 0.0% |
| Q3 2015 | $8,684,000 | +33.4% | 291,800 | +43.4% | 0.00% | +100.0% |
| Q2 2015 | $6,508,000 | +217.9% | 203,507 | +106.1% | 0.00% | – |
| Q1 2015 | $2,047,000 | +27.7% | 98,731 | +4.3% | 0.00% | – |
| Q4 2014 | $1,603,000 | -11.9% | 94,622 | +0.5% | 0.00% | – |
| Q3 2014 | $1,820,000 | -55.7% | 94,138 | -22.0% | 0.00% | -100.0% |
| Q2 2014 | $4,104,000 | -14.1% | 120,700 | -20.4% | 0.00% | 0.0% |
| Q1 2014 | $4,775,000 | – | 151,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |